OPEN MARKET SALE AGREEMENTOpen Market Sale Agreement • March 13th, 2020 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.00001 per share (the “Common Shares”), having an aggregate offering price of up to $25,000,000 on the terms set forth in this agreement (this “Agreement”).
